The short version of GLP-1 receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-23 and is reviewed periodically as new material appears.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
The Shalwar kameez is Pakistan's national dress, worn in all provinces: Punjab, Sindh, Balochistan, Khyber Pakhtunkhwa, and Azad Kashmir. Each province has its own style. Pakistanis wear a variety of fabrics like silk, chiffon, and cotton. In addition to the national dress, men often wear domestically tailored suits and neckties, especially in offices, schools, and social gatherings. Pakistan's fashion industry has thrived, blending traditional and modern styles to create a unique cultural identity. Regional and traditional dress remain significant symbols of native tradition, evolving into both modern and purer forms. Organisations like the Pakistan Fashion Design Council in Lahore and the Fashion Pakistan Council in Karachi host events like PFDC Fashion Week and Fashion Pakistan Week. Pakistan's inaugural fashion week took place in November 2009.
=== Legal status === In October 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Cibinqo, intended for the treatment of atopic dermatitis. The applicant for this medicinal product is Pfizer Europe MA EEIG. In December 2021, the European Commission approved abrocitinib for the treatment of atopic dermatitis. In January 2022, the US Food and Drug Administration (FDA) approved abrocitinib for adults with moderate-to-severe atopic dermatitis.
The cause of capsular contracture is unknown, but the common incidence factors include bacterial contamination, device-shell rupture, filler leakage, and hematoma. The surgical implantation procedures that have reduced the incidence of capsular contracture include submuscular emplacement, the use of breast implants with a textured surface (polyurethane-coated); limited pre-operative handling of the implants, limited contact with the chest skin of the implant pocket before the emplacement of the breast implant, and irrigation of the recipient site with triple-antibiotic solutions. The correction of capsular contracture might require an open capsulotomy (surgical release) of the collagen-fiber capsule, or the removal, and possible replacement, of the breast implant. Furthermore, in treating capsular contracture, the closed capsulotomy (disruption via external manipulation) once was a common maneuver for treating hard capsules, but now is a discouraged technique, because it can rupture the breast implant. Non-surgical treatments for collagen-fiber capsules include massage, external ultrasonic therapy, leukotriene pathway inhibitors such as zafirlukast (Accolate) or montelukast (Singulair), and pulsed electromagnetic field therapy (PEMFT).
Sources: en.wikipedia.org
{\displaystyle C_{Cr}={\frac {\mathrm {1.25\ mg/mL\times {\frac {60\ mL}{60\ min}}} }{\mathrm {0.01\ mg/mL} }}={\frac {\mathrm {{1.25\ mg/mL}\times {1\ mL/min}} }{\mathrm {0.01\ mg/mL} }}={\frac {\mathrm {1.25\ mg/min} }{\mathrm {0.01\ mg/mL} }}=\mathrm {125\ mL/min} }
== Production == The series is a Movistar Plus+ original, produced in collaboration with Suma Content. Shooting locations in Catalonia included Barcelona, Girona, Mataró, Òrrius, Santa Eulàlia de Ronçana, Calaf, Arenys de Mar, Manresa, Gualba, and Santa Susanna. The series was lensed by Gris Jordana. Raül Refree (score) and Hidrogenesse (original songs) were responsible for the music.
== Nutritional profile == Sirloin steak is a nutrient-dense source of protein and contains essential micronutrients. A 100 g serving of cooked sirloin steak typically provides 200-313 kilocalories. It contains 28-30 g of protein, 0 g of carbohydrates and 9-21 g of fat, depending on the cooking method and trimming. The cut is generally leaner than heavily marbled steaks, such as ribeye, which results in a lower total fat content. A 100 g sirloin steak also contains 2–3 mg of iron and 3 mg of vitamin B12. These vitamins are important for oxygen transport and neurological function.
Sources: en.wikipedia.org
More data on this classification are discoverable at the Expasy metallothionein page.Secondary structure elements have been observed in several MTs SmtA from Syneccochoccus, mammalian MT3, echinoderm SpMTA, fish Notothenia coriiceps MT, crustacean MTH, but until this moment, the content of such structures is considered to be poor in MTs, and its functional influence is not considered. Tertiary structure of MTs is also highly heterogeneous. While vertebrate, echinoderm and crustacean MTs show a bidominial structure with divalent metals as Zn(II) or Cd(II) (the protein is folded so as to bind metals in two functionally independent domains, with a metallic cluster each), yeast and prokaryotic MTs show a monodominial structure (one domain with a single metallic cluster). In yeast, the first 40 residues in the protein wrap around the metal by forming two large parallel loops separated by a deep cleft containing the metal cluster. Although no structural data is available for molluscan, nematoda and Drosophila MTs, it is commonly assumed that the former are bidominial and the latter monodominial. No conclusive data are available for Plant MTs, but two possible structures have been proposed: 1) a bidominial structure similar to that of vertebrate MTs; 2) a codominial structure, in which two Cys-rich domains interact to form a single metallic cluster. Quaternary structure has not been broadly considered for MTs.
Type II megastructures would be easier to detect. This would be the case of a Dyson sphere used as a "stellar engine", as well as the contribution of heavy elements. Similarly, "Shkadov thrusters", which would produce a lateral thrust of 4.4 parsecs on their star by reflecting solar radiation through a structure made of mirrors, would be observable objects. This device would break the symmetry of solar radiation and counteract gravitational forces, allowing a Type II civilization to move its home solar system through space. Drake and Shklovski have also considered the possibility of "seeding" a star (Stellar salting) by artificially adding extremely rare elements such as technetium or promethium. Such an intervention in a star's composition would be detectable. It is still possible that humanity could discover traces of lost Type I, II, or III civilizations. The search for material traces of such civilizations (e.g. Dyson spheres or stellar engines), an "interesting alternative" to the conventional SETI program, lays the foundation for a "cosmic archaeology" according to Richard A. Carrigan. Efforts to detect intelligence markers in the atmospheres of exoplanets (such as freon, oxygen, or even ozone, residues of biotic activity according to James Lovelock's research) are one of the most promising avenues. A civilization watching its star die (as a red giant, for example) could have tried to prolong its existence through megastructures that should be detectable.
== Stability == The stability of a nanoparticle is a term often used to describe the preservation of a specific, usually size-dependent, property of the particle. It can refer to e.g.: its size, shape, composition, crystalline structure, surface properties or dispersion within a solution. The interfacial layer of a nanoparticle can aid these types of stabilities in different ways. The ligands can bind to the different facets of a nanoparticle, the size and type of which will determine the way the ligands will be ordered. The way the ligands are attached to the particle, ordered disordered or somewhere in between, plays a crucial role in the way different particles will interact. This in turn affects the reactivity of the nanoparticle, which is another way to look at the stability of the particle.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
Solid material is normally kept frozen at about -20 degrees Celsius, desiccated and protected from light. Solutions are held cold and used within a defined window because degradation products accumulate over time.